Compare TTK HEALTHCARE with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE IPCA LABS TTK HEALTHCARE/
IPCA LABS
 
P/E (TTM) x 19.3 23.0 83.7% View Chart
P/BV x 1.5 4.4 35.0% View Chart
Dividend Yield % 1.0 0.3 363.8%  

Financials

 TTK HEALTHCARE   IPCA LABS
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
IPCA LABS
Mar-19
TTK HEALTHCARE/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs1,2151,042 116.6%   
Low Rs610590 103.4%   
Sales per share (Unadj.) Rs444.4298.6 148.8%  
Earnings per share (Unadj.) Rs17.235.0 49.3%  
Cash flow per share (Unadj.) Rs27.649.4 55.9%  
Dividends per share (Unadj.) Rs5.003.00 166.7%  
Dividend yield (eoy) %0.50.4 149.0%  
Book value per share (Unadj.) Rs177.9247.1 72.0%  
Shares outstanding (eoy) m14.13126.35 11.2%   
Bonus/Rights/Conversions -ESOS-  
Price / Sales ratio x2.12.7 75.2%   
Avg P/E ratio x52.923.3 226.9%  
P/CF ratio (eoy) x33.016.5 200.1%  
Price / Book Value ratio x5.13.3 155.3%  
Dividend payout %29.08.6 338.2%   
Avg Mkt Cap Rs m12,894103,108 12.5%   
No. of employees `0002.313.4 17.2%   
Total wages/salary Rs m1,3077,874 16.6%   
Avg. sales/employee Rs Th2,715.72,807.0 96.7%   
Avg. wages/employee Rs Th565.3585.8 96.5%   
Avg. net profit/employee Rs Th105.4329.0 32.0%   
INCOME DATA
Net Sales Rs m6,27937,732 16.6%  
Other income Rs m78577 13.4%   
Total revenues Rs m6,35638,309 16.6%   
Gross profit Rs m4966,901 7.2%  
Depreciation Rs m1471,824 8.0%   
Interest Rs m34189 17.9%   
Profit before tax Rs m3935,465 7.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1491,042 14.3%   
Profit after tax Rs m2444,422 5.5%  
Gross profit margin %7.918.3 43.2%  
Effective tax rate %37.919.1 198.8%   
Net profit margin %3.911.7 33.1%  
BALANCE SHEET DATA
Current assets Rs m2,71723,778 11.4%   
Current liabilities Rs m1,57110,975 14.3%   
Net working cap to sales %18.333.9 53.8%  
Current ratio x1.72.2 79.8%  
Inventory Days Days32104 31.0%  
Debtors Days Days4766 70.8%  
Net fixed assets Rs m99120,368 4.9%   
Share capital Rs m141253 55.9%   
"Free" reserves Rs m2,37330,971 7.7%   
Net worth Rs m2,51431,224 8.1%   
Long term debt Rs m31,409 0.2%   
Total assets Rs m4,15845,507 9.1%  
Interest coverage x12.630.0 42.1%   
Debt to equity ratio x00 3.0%  
Sales to assets ratio x1.50.8 182.1%   
Return on assets %6.710.1 65.9%  
Return on equity %9.714.2 68.4%  
Return on capital %16.917.3 97.8%  
Exports to sales %3.645.9 7.8%   
Imports to sales %0.516.6 3.0%   
Exports (fob) Rs m22517,308 1.3%   
Imports (cif) Rs m316,266 0.5%   
Fx inflow Rs m22517,308 1.3%   
Fx outflow Rs m716,266 1.1%   
Net fx Rs m15411,042 1.4%   
CASH FLOW
From Operations Rs m1734,923 3.5%  
From Investments Rs m97-1,563 -6.2%  
From Financial Activity Rs m-307-1,832 16.8%  
Net Cashflow Rs m-381,528 -2.5%  

Share Holding

Indian Promoters % 65.4 45.9 142.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 11.4 32.5%  
FIIs % 5.2 25.3 20.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 17.4 148.3%  
Shareholders   12,723 36,892 34.5%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   TORRENT PHARMA  NATCO PHARMA  DIVIS LABORATORIES  SANOFI INDIA  ALKEM LABORATORIES  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Open Marginally Higher; Healthcare Stocks Witness Buying(09:30 am)

Asian share markets are trading on a negative note today as Japanese and Hong Kong shares show losses. The Nikkei 225 is down 0.79% while the Hang Seng is down 1.73%.

Related Views on News

IPCA LABS Announces Quarterly Results (2QFY20); Net Profit Up 63.7% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 63.7% YoY). Sales on the other hand came in at Rs 12 bn (up 21.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY20); Net Profit Up 101.5% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 101.5% YoY). Sales on the other hand came in at Rs 10 bn (up 18.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Nov 11, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - DR. DATSONS LABS COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS